S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Kiwa Bio-Tech Products Group Stock Forecast, Price & News

0.00 (0.00%)
(As of 12/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume
171,135 shs
Market Capitalization
$246.73 thousand
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive KWBT News and Ratings via Email

Sign-up to receive the latest news and ratings for Kiwa Bio-Tech Products Group and its competitors with MarketBeat's FREE daily newsletter.

Kiwa Bio-Tech Products Group logo

About Kiwa Bio-Tech Products Group

Kiwa Bio-Tech Products Group Corp. engages in the development, manufacture and distribution of environmentally safe bio-technological products for agriculture. Its products include biological organic fertilizer series, compound microbial fertilizer series, biological water soluble fertilizer series, microorganism bacterial agent series, and biological soil remediation series. The company was founded by Wei Li on June 5, 2002 and is headquartered in Ontario, CA.


See More Headlines

Industry, Sector and Symbol

Agricultural chemicals
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$40.09 million
Book Value
$0.07 per share


Pretax Margin




Free Float
Market Cap
$246.73 thousand
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

1.06 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) Frequently Asked Questions

How has Kiwa Bio-Tech Products Group's stock price been impacted by COVID-19?

Kiwa Bio-Tech Products Group's stock was trading at $0.0128 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, KWBT stock has decreased by 96.9% and is now trading at $0.0004.
View which stocks have been most impacted by COVID-19

How were Kiwa Bio-Tech Products Group's earnings last quarter?

Kiwa Bio-Tech Products Group Co. (OTCMKTS:KWBT) announced its earnings results on Tuesday, November, 20th. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $7.73 million for the quarter.
View Kiwa Bio-Tech Products Group's earnings history

Who are Kiwa Bio-Tech Products Group's key executives?

Kiwa Bio-Tech Products Group's management team includes the following people:
  • Wade Li, Chairman, President & Chief Executive Officer
  • Xiao Qiang Yu, Chief Operating Officer & Director
  • Hon Man Yun, CFO & Principal Accounting Officer
  • Qi Wang, Director & Vice President-Technology
  • Wei Jun Xu, Chief Scientific Officer

What other stocks do shareholders of Kiwa Bio-Tech Products Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kiwa Bio-Tech Products Group investors own include Co-Diagnostics (CODX), BioRestorative Therapies (BRTX), FuelCell Energy (FCEL), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aurora Cannabis (ACB) and Ascent Solar Technologies (ASTI).

What is Kiwa Bio-Tech Products Group's stock symbol?

Kiwa Bio-Tech Products Group trades on the OTCMKTS under the ticker symbol "KWBT."

How do I buy shares of Kiwa Bio-Tech Products Group?

Shares of KWBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Kiwa Bio-Tech Products Group's stock price today?

One share of KWBT stock can currently be purchased for approximately $0.00.

How much money does Kiwa Bio-Tech Products Group make?

Kiwa Bio-Tech Products Group has a market capitalization of $246.73 thousand and generates $40.09 million in revenue each year.

How many employees does Kiwa Bio-Tech Products Group have?

Kiwa Bio-Tech Products Group employs 16 workers across the globe.

What is Kiwa Bio-Tech Products Group's official website?

The official website for Kiwa Bio-Tech Products Group is www.kiwabiotech.com.

Where are Kiwa Bio-Tech Products Group's headquarters?

Kiwa Bio-Tech Products Group is headquartered at 3200 Guasti Road Suite #100, Ontario CA, 91761.

How can I contact Kiwa Bio-Tech Products Group?

Kiwa Bio-Tech Products Group's mailing address is 3200 Guasti Road Suite #100, Ontario CA, 91761. The company can be reached via phone at (909) 456-8828, via email at [email protected], or via fax at 626-626-7665.

This page was last updated on 12/5/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.